Safety and Modulation of ABCC9 Pathways by Nicorandil for the Treatment of Hippocampal Sclerosis of Aging
Clinical trial NCT04120766 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04120766
- Sponsor
- Gregory Jicha, MD, PhD
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-01
- Primary completion
- 2026-09-01
- Enrollment
- 64
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.